The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major pharmaceutical companies and investors alike. With Bloomberg Intelligence estimating that the Alzheimer’s treatment market could reach $13 billion by 2030, the stakes are high. Leading firms such as Biogen Inc., Eli Lilly &…
Elon Musk’s X, the social media platform formerly known as Twitter, is introducing profile labels to clearly identify parody,…
President Joe Biden’s administration is set to announce short-term guidance on clean fuel tax credits on Friday, according to…
Italian luxury brand Prada may be considering acquiring Versace, according to a report from Il Sole 24 Ore. The…
The DAX index has started the year well, rising for five consecutive days and hovering near its highest level…
Apple Pay users faced a frustrating disruption on Wednesday afternoon as the payment service, particularly Apple Cash, experienced widespread…
The Biden administration is preparing a final round of export restrictions on advanced artificial intelligence (AI) chips, marking a…
Asian stock markets traded mostly lower on Thursday, taking mixed cues from Wall Street amid persistent uncertainty over interest…
Reliance’s share price has corrected by almost 22% from its 52-week high, and with the company set for a recovery…